SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1orf'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1AQ7_B_AG2B4_1
(TRYPSIN
AERUGINOSIN 98-B)		 1orf GRANZYME A
(Homo
sapiens) 		6 / 8 HIS A  57
ASP A 189
SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.7A)
0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.55A 1aq7A-1orfA:
34.3		 1aq7A-1orfA:
35.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1ETR_H_MITH1_1
(EPSILON-THROMBIN)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 HIS A  57
ASP A 189
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.7A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.65A 1etrH-1orfA:
31.3		 1etrH-1orfA:
30.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1F5L_A_AMRA301_1
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 8 ASP A 189
SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.36A 1f5lA-1orfA:
11.7		 1f5lA-1orfA:
29.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1I9G_A_SAMA301_0
(HYPOTHETICAL PROTEIN
RV2118C)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 ILE A  40
GLY A  44
GLY A 196
SER A 195
LEU A  46
 None
None
None
0G6  A   1 (-1.3A)
None
 1.14A 1i9gA-1orfA:
undetectable		 1i9gA-1orfA:
19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IGX_A_EPAA700_1
(PROSTAGLANDIN
ENDOPEROXIDE H
SYNTHASE-1)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.11A 1igxA-1orfA:
undetectable		 1igxA-1orfA:
19.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MUI_B_AB1B100_1
(PROTEASE)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 10 GLY A  44
ALA A  45
GLY A 211
ILE A 229
ILE A  47
 None
 0.96A 1muiA-1orfA:
undetectable		 1muiA-1orfA:
16.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TNL_A_TPAA900_1
(TRYPSIN)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 6 ASP A 189
SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.31A 1tnlA-1orfA:
12.8		 1tnlA-1orfA:
35.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2BM9_A_SAMA301_1
(CEPHALOSPORIN
HYDROXYLASE CMCI)		 1orf GRANZYME A
(Homo
sapiens) 		3 / 3 LYS A 104
ASP A  36
ASN A  59
 None
 1.14A 2bm9A-1orfA:
undetectable		 2bm9A-1orfA:
23.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2NMY_A_ROCA401_1
(PROTEASE)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 GLY A  44
ALA A  45
GLY A 211
ILE A 229
ILE A  47
 None
 0.87A 2nmyA-1orfA:
undetectable		 2nmyA-1orfA:
15.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2OTV_A_NCAA1301_0
(CATIONIC TRYPSIN)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 6 ASP A 189
SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.22A 2otvA-1orfA:
12.8		 2otvA-1orfA:
35.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2P16_A_GG2A298_1
(COAGULATION FACTOR X
(EC 3.4.21.6)
(STUART FACTOR)
(STUART-PROWER
FACTOR))		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 ASP A 189
SER A 195
GLY A 216
GLY A 226
TYR A 228
 0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
None
 0.31A 2p16A-1orfA:
12.8		 2p16A-1orfA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD4_A_CHDA803_0
(FERROCHELATASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 5 LEU A 123
PRO A 124
LEU A 235
ILE A 238
 None
 0.87A 2qd4A-1orfA:
undetectable		 2qd4A-1orfA:
19.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VIN_A_505A1247_1
(UROKINASE-TYPE
PLASMINOGEN
ACTIVATOR CHAIN B)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 8 ASP A 189
SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.40A 2vinA-1orfA:
10.7		 2vinA-1orfA:
29.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W26_A_RIVA1001_1
(ACTIVATED FACTOR XA
HEAVY CHAIN)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 ASP A 189
SER A 195
GLY A 216
GLY A 226
TYR A 228
 0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
None
 0.35A 2w26A-1orfA:
11.6		 2w26A-1orfA:
29.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YFX_A_VGHA9000_1
(TYROSINE-PROTEIN
KINASE RECEPTOR)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 8 LEU A  53
ALA A  45
MET A  30
GLY A 211
ASP A 194
 None
 1.40A 2yfxA-1orfA:
undetectable		 2yfxA-1orfA:
19.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKX_B_1UNB201_1
(PROTEASE)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 11 GLY A  44
ALA A  45
GLY A 211
ILE A 229
ILE A  47
 None
 0.94A 3ekxA-1orfA:
undetectable		 3ekxA-1orfA:
17.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3GY3_A_PNTA246_0
(CATIONIC TRYPSIN)		 1orf GRANZYME A
(Homo
sapiens) 		6 / 11 HIS A  57
ASP A 189
SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.7A)
0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.39A 3gy3A-1orfA:
12.6		 3gy3A-1orfA:
35.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HEG_A_BAXA1_2
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 6 VAL A 212
ILE A 238
HIS A 234
ILE A 229
LEU A 230
 None
 1.36A 3hegA-1orfA:
undetectable		 3hegA-1orfA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N8X_A_NIMA701_1
(PROSTAGLANDIN G/H
SYNTHASE 1)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.20A 3n8xA-1orfA:
0.0		 3n8xA-1orfA:
19.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N8Y_A_DIFA701_1
(PROSTAGLANDIN G/H
SYNTHASE 1)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 11 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.17A 3n8yA-1orfA:
undetectable		 3n8yA-1orfA:
19.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RXF_A_4APA9_1
(CATIONIC TRYPSIN)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 6 SER A 190
SER A 195
GLY A 216
GLY A 226
 0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.3A)
0G6  A   1 (-3.5A)
 0.28A 3rxfA-1orfA:
13.7		 3rxfA-1orfA:
35.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3RXH_A_HSMA7_1
(CATIONIC TRYPSIN)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 5 ASP A 189
SER A 190
SER A 195
GLY A 226
 0G6  A   1 (-2.9A)
0G6  A   1 (-2.9A)
0G6  A   1 (-1.3A)
0G6  A   1 (-3.5A)
 0.31A 3rxhA-1orfA:
12.8		 3rxhA-1orfA:
35.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S54_B_017B201_1
(PROTEASE)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 GLY A  44
ALA A  45
GLY A 211
ILE A 229
ILE A  47
 None
 0.89A 3s54A-1orfA:
undetectable		 3s54A-1orfA:
18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TEH_B_DAHB786_1
(PHENYLALANYL-TRNA
SYNTHETASE BETA
CHAIN)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 PRO A 198
LEU A 106
ALA A  45
PHE A 209
 None
 0.98A 3tehB-1orfA:
undetectable		 3tehB-1orfA:
14.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4F4D_B_CHDB504_0
(FERROCHELATASE,
MITOCHONDRIAL)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 4 LEU A 123
PRO A 124
LEU A 235
ILE A 238
 None
 0.99A 4f4dB-1orfA:
undetectable		 4f4dB-1orfA:
19.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FGL_D_CLQD303_0
(RIBOSYLDIHYDRONICOTI
NAMIDE DEHYDROGENASE
[QUINONE])		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 GLY A  44
VAL A  31
PHE A 209
ILE A  47
 None
 0.79A 4fglC-1orfA:
undetectable		 4fglC-1orfA:
21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RRW_A_LURA705_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.08A 4rrwA-1orfA:
undetectable		 4rrwA-1orfA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RRW_B_LURB705_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.10A 4rrwB-1orfA:
undetectable		 4rrwB-1orfA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RRW_C_LURC705_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.06A 4rrwC-1orfA:
undetectable		 4rrwC-1orfA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RRZ_A_LURA705_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.08A 4rrzA-1orfA:
undetectable		 4rrzA-1orfA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RRZ_B_LURB705_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.10A 4rrzB-1orfA:
undetectable		 4rrzB-1orfA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RRZ_C_LURC705_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.06A 4rrzC-1orfA:
undetectable		 4rrzC-1orfA:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UXQ_A_0LIA1752_2
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 ILE A 120
ALA A 112
ARG A 210
ILE A  47
 None
 0.83A 4uxqA-1orfA:
undetectable		 4uxqA-1orfA:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XE3_B_CL6B502_1
(CYTOCHROME P-450)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 5 LEU A 108
ALA A  48
VAL A 118
ILE A 114
 None
 0.93A 4xe3B-1orfA:
undetectable		 4xe3B-1orfA:
19.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XUE_A_SAMA303_1
(CATECHOL
O-METHYLTRANSFERASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 5 GLY A 101
TYR A 228
SER A 214
GLU A 100
 None
 1.19A 4xueA-1orfA:
undetectable		 4xueA-1orfA:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_A_SORA1342_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 ILE A 229
LYS A 104
LEU A 103
GLY A 101
 None
 0.84A 5a06A-1orfA:
undetectable		 5a06A-1orfA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_C_SORC1342_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 ILE A 229
LYS A 104
LEU A 103
GLY A 101
 None
 0.82A 5a06C-1orfA:
undetectable		 5a06C-1orfA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_E_SORE1341_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 ILE A 229
LYS A 104
LEU A 103
GLY A 101
 None
 0.84A 5a06E-1orfA:
undetectable		 5a06E-1orfA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5A06_F_SORF1341_0
(ALDOSE-ALDOSE
OXIDOREDUCTASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 7 ILE A 229
LYS A 104
LEU A 103
GLY A 101
 None
 0.82A 5a06F-1orfA:
undetectable		 5a06F-1orfA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEN_A_5OGA804_1
(HDAC6 PROTEIN)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 PRO A 175
SER A 214
PHE A 215
GLY A 224
TYR A 172
 0G6  A   1 ( 4.9A)
None
0G6  A   1 (-4.8A)
None
None
 1.30A 5eenA-1orfA:
undetectable		 5eenA-1orfA:
19.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKR_A_ID8A601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 LEU A 155
TYR A  29
GLY A  44
ALA A  43
SER A 197
 None
 1.16A 5ikrA-1orfA:
undetectable		 5ikrA-1orfA:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IKT_A_TLFA601_1
(PROSTAGLANDIN G/H
SYNTHASE 2)		 1orf GRANZYME A
(Homo
sapiens) 		3 / 3 LEU A 155
TYR A  29
SER A 197
 None
 0.90A 5iktA-1orfA:
0.0		 5iktA-1orfA:
18.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5UL4_A_SAMA803_0
(OXSB PROTEIN)		 1orf GRANZYME A
(Homo
sapiens) 		5 / 12 ARG A 156
GLY A 142
LYS A  16
GLY A 193
LEU A 200
 None
None
None
0G6  A   1 (-3.6A)
None
 1.15A 5ul4A-1orfA:
undetectable		 5ul4A-1orfA:
19.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6H7U_A_FVTA501_0
(PEPTIDE ABC
TRANSPORTER PERMEASE)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 6 VAL A 227
ASN A 179
ILE A 229
GLU A 100
 None
 1.06A 6h7uA-1orfA:
undetectable		 6h7uA-1orfA:
17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HU9_H_PCFH604_0
(CYTOCHROME B-C1
COMPLEX SUBUNIT 8
CYTOCHROME C OXIDASE
POLYPEPTIDE 5A,
MITOCHONDRIAL)		 1orf GRANZYME A
(Homo
sapiens) 		4 / 8 GLY A 216
GLY A 193
SER A 195
ALA A  55
 0G6  A   1 (-3.3A)
0G6  A   1 (-3.6A)
0G6  A   1 (-1.3A)
None
 0.76A 6hu9H-1orfA:
undetectable
6hu9e-1orfA:
undetectable		 6hu9H-1orfA:
16.38
6hu9e-1orfA:
19.15